This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Enteral Feeding Study of Formula Containing Fish Oil in Critical Care Setting

This study has been terminated.
(Unable to meet enrollment goal)
Information provided by (Responsible Party):
Nestlé Identifier:
First received: January 12, 2007
Last updated: October 31, 2013
Last verified: October 2013
The purpose of this study is to evaluate the clinical applicability of an enteral tube feeding formula containing fish oil and prebiotics in a critical care population.

Condition Intervention
Trauma Tube Feeding Procedure: Tube feeding

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Use of a High-protein Enteral Formula Containing Prebiotics and Fish Oil in Critical Care

Resource links provided by NLM:

Further study details as provided by Nestlé:

Primary Outcome Measures:
  • Clinical applicability as measured by the length of time between start of feeding to the first achievement of 800ml/day

Secondary Outcome Measures:
  • Gastrointestinal tolerance
  • Time to advance to full feed
  • Inflammatory markers
  • Infection

Estimated Enrollment: 50
Study Start Date: January 2007
Study Completion Date: August 2008
Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
Detailed Description:

In terms of nutrition support in the acute care setting, it is generally accepted that

  1. earlier is better
  2. enteral is superior to parenteral
  3. the quality of nutrients appears more important than quantity
  4. select populations will show additional benefit from specific nutrient supplementation.

The current study is designed to evaluate the tolerance of an enteral formula in trauma and surgery patients, as demonstrated by achieving and maintaining enteral feeding goal, gastrointestinal tolerance and inflammatory markers.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • 18 - 70 years old
  • New ICU admit
  • Enteral tube feeding anticipated for at least 7 days
  • Informed consent

Exclusion Criteria:

  • Enteral tube feeding immediately prior to admit
  • Parenteral feeding
  • Medical condition that preclude receiving tube feeding or formula
  • Determined by PI to be inappropriate
  • Participating in another clinical trial
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00421941

United States, Oregon
Oregon Health & Science University
Portland, Oregon, United States, 97239
Sponsors and Collaborators
Principal Investigator: Robert Martindale, MD, PhD Oregon Health and Science University
  More Information

Responsible Party: Nestlé Identifier: NCT00421941     History of Changes
Other Study ID Numbers: 06.06.US.HCN
Study First Received: January 12, 2007
Last Updated: October 31, 2013

Keywords provided by Nestlé:
enteral feeding
critical care
fish oil
surgical processed this record on August 22, 2017